Clinical Trials Browser

Solid Tumor × osimertinib × 90 days × Clear all

NCT07612137 2026-05-28

Study of IBI3005 Combination Therapy in Participants With Unresectable, Locally Advanced or Metastatic Solid Tumors

Phase 1/2 Not yet recruiting

Other solid neoplasm

Solid Tumor